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ABSTRACT OF DISSERTATION

Structural basis of bacterial flagellin for NAIP5 binding and NLRC4 inflammasome
activation and the mechanism of flagellin induced release of cytokines in vivo
The bacterial flagellum is a whip-like structure that protrudes from the cell
membrane and is one of the most complex and dynamic biological molecular machines
that propels bacteria to swim toward beneficial environments and the sites of infection. It
is composed of a basal body, a hook, and a long filament. The flagellar filament contains
thousands of copies of the protein flagellin (FliC) monomer arranged helically and ending
with a filament cap composed of oligomer protein FliD. The overall structure of the
filament core is preserved across bacterial species, while the outer domains exhibit high
variability, and in some cases are even completely absent. Apart from its role in
locomotion, the filament is critically important in several other aspects of bacterial
survival, reproduction, and pathogenicity, such as adhesion to surfaces, secretion of
effector molecules, penetration through tissue structures, and biofilms formation.
Bacterial flagellin is an important pathogen-associated molecular pattern (PAMP),
which can activate both innate and adaptive immunity. Previous in vitro studies indicate
that TLR5 is a major extracellular receptor for flagellin that mediates flagellin-induced
production of proinflammatory cytokines, including interleukin-6 (IL-6), IL-12, and tumor
necrosis factor α (TNFα). Flagellin can also induce inflammasome activation through its
intracellular receptor, the NLR family apoptosis inhibitory protein (NAIP) 5 and 6, leading
to the generation of cytokines IL-1β and IL-18, as well as pyroptosis. Here, we found that
inflammasome activation and subsequent pyroptosis, but not TLR5-mediated signal
transduction, is responsible for flagellin-induced IL-6 and TNFα generation in vivo.
Flagellin was fused to the cytosolic translocation domain of anthrax lethal factor (LFn) to
enable efficient cytosolic delivery. LFn binds to anthrax protein protective antigen (PA),
which delivers the LFn-flagellin fusion protein into the cytoplasm through receptormediated endocytosis. Injection of LFn-flagellin with PA, but not LFn-flagellin alone by i.
v., increased plasma concentrations of IL-1β, IL-6, and TNFα. LFn-flagellin/PA induced
IL-1β, IL-6, and TNFα release was abolished in mice deficient in NAIPs, caspase-1, or

GSDMD, but not TLR5. Depletion of monocytes and macrophages using clodronate
inhibited LFn-flagellin/PA induced cytokine release. In addition, injection of the LFn
fusion of another virulent factor, the T3SS rod protein EprJ from E. coli, together with PA
also induced generation of IL-1β, IL-6, and TNFα in a caspase-1 and GSDMD dependent
manner. Our data indicate that inflammasome activation leads to the generation of a broad
range of inflammatory cytokines in vivo through pyroptosis, suggesting an important role
of pyroptosis in cytokine storm.
Flagellin is a widespread bacterial virulence factor sensed by the membrane-bound
Toll-like receptor 5 (TLR5) and by the intracellular NAIP5/NLRC4 inflammasome
receptor. Bacterial flagellin is composed of highly conserved D0 and D1 domain, as well
as hypervariable D2 and D3 domain. It has been reported that deletion of the D0 domain
of flagellin completely abrogates the activation of TLR5. D0 domain of flagellin alone can
bind NAIP5/6, leading to activation of the NLRC4 inflammasome, while whether the D1
domain of flagellin plays any functional role in NAIP5/NLRC4 inflammasome activation
remains elusive. Besides, flagellins from S. typhimurium, Yersiniosis enterocolitica, and
Pseudomonas aeruginosa can bind to NAIP5/6 and activate inflammasome NLRC4, those
from enteropathogenic E. coli, enterohaemorrhagic E. coli, Shigella flexneri, and
Burkholderia thailandensis cannot interact with NAIP5/6 and are unable to activate the
inflammasome NLRC4. Replacement of the C-terminal D1 domain of flagellin from P.
aeruginosa with the C-terminal D1 domain of E. coli flagellin diminished inflammasome
activation. These data reveal that the D1 domain also plays an important role in flagellininduced NAIP/NLRC4 inflammasome activation.
KEYWORDS: bacteria flagellin, virulence factors, PAMP, TLR5, NAIP/NLRC4
inflammasome activation, pyroptosis, cytokines
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CHAPTER 1.

1.1

INTRODUCTION

Introduction
Human health is constantly threatened by various infectious diseases and large-

scale epidemics caused by bacteria. Bacterial infections have been threatening mankind
since its first existence. Infectious diseases are the second leading cause of death worldwide
and the most significant cause of death in children, causing about 5 million children die
from infectious diseases every year.[1-4] Sepsis is the body’s extreme response to an
infection and a life-threatening condition that affects more than 1 million patients a year in
the United States.[5, 6] It is a leading cause of death in ICU, with an incidence of about 2.5
per 1,000 people in the western world. Over the past two decades, the annual growth rate
of sepsis is almost 10%.[7] About 20% of people with sepsis die in hospitals, and severe
sepsis can cause about 40% of deaths.[8] Massive and sudden production of inflammatory
cytokines is called cytokine storm, which is dysregulated acute inflammation response
triggered by infections and other stress signals such as trauma.[9] Cytokine storm has been
associated frequently with detrimental clinical outcomes. Pro-inflammatory cytokines IL1β, IL-6, and TNFα play important roles in cytokine storm and are popular biomarkers
used in monitoring cytokine release during inflammatory responses as their concentrations
in blood correlates with the severity of infection.[10-13] IL-1β binds to the IL-1 receptor
on the surface of immune cells and triggers various processes and expression of cytokines
and chemokines.[14, 15] IL-6 interacts with its membrane receptor IL-6R (composed of
receptor IL-6Rα and signal transducer gp130) expressed in lymphocytes, myeloid cells,
and hepatocytes to activate Janus kinase (JAK) family tyrosine kinases, leading to the
1

activation of signal transducer and activator of transcription (STAT) family transcription
factors.[16] Later it was found that when complexed with the soluble form of IL-6Rα, IL6 can activate non-immune cells expressing only gp130.[17] Production of TNFα is
triggered under various pathophysiological conditions including infection.[18, 19] TNFα
exists in two forms, a membrane bound form and a soluble form, which corresponding to
the extracellular domain of the former. Activity of TNFα is mediated by two receptors,
TNFR1 (expressed on the surface of most human cell types) and TNFR2 (located mainly
on immune and endothelial cells).[20] TNFR1 stimulation leads to inflammation or cell
death, while TNFR2 signaling supports cell activation, migration, and proliferation.[12]
Virulence factors are molecules that assist bacteria to colonize the host at the cellular level.
The membrane-associated virulence factors aid the bacterium in adhesion and evasion of
the host cell. The investigation of the structural basis and mechanism of virulence factors
in infectious diseases is essential for the development of new therapeutic methods. As a
common virulence factor from flagellated bacteria, flagellin promotes pathogens to adhere,
invade, and proliferate in host cells and stimulates innate immune responses, which
contributes to the immediate clearance of pathogens from the host.[21-25]

1.2

Structure and function of flagellin
The bacterial flagellum is known as one of the most complex and dynamic

biological nanomachines and has attracted attention since its discovery in the late
nineteenth century. The flagellum is a whip-like filament attached to the surface of bacteria,
providing the major force for bacterial motility. The number of flagella per cell varies
depending on the species. Monotrichous specie contains only one flagellum at the pole
2

(e.g., Pseudomonas aeruginosa); lophotrichous specie has multiple flagella form a bundle
at the same pole on the cell (e.g., Helicobacter pylori); amphitrichous bacterium has one
flagellum at each pole (e.g., Campylobacter jejuni); and peritrichous bacterium contains
multiple flagella (e.g., Escherichia coli, Salmonella enterica).[26] The flagella polymer is
composed of repeated helix stacking of flagellin monomers. Early biophysical
characterization showed that the N- and C-termini of monomeric flagellin are mainly
disordered and critical for polymerization, although they become highly structured in the
filament.[27, 28] Monomeric flagellin (30-60kDa, depending on the species of bacteria) is
secreted by the bacteria through the flagella export system. Structurally, the carboxyl (C)
terminus of flagellin folds back to the amino terminus (N); the whole molecule contains
four different globular domains, D0, D1, D2, and D3, forming a "boomerang".[29] (Figure
1.1) There are about 40 amino acids at each terminus of the flagellin molecule that makes
up the D0 domain. The D1 domain contains approximately 100 residues from the Nterminus and 50 residues from the C-terminus. Flagella are stacked longitudinally to form
a profilament unit through the intermolecular contact between two adjacent monomer D1
domains. A total of 11 profilaments are assembled into flagella filaments. (Figure 1.2) The
flagella filament is a hollow tube about 15 microns long, with an external diameter and an
inner diameter of about 240 Å and 20 Å, respectively.[30] The D0 and adjacent D1 domains
constitute the inner and outer core of the hollow filament; the D2 and D3 domains come
from the central segment of the flagellin polypeptide and are derived from the projections
on the outer surface of the flagellin.[29, 30] Both D0 and D1 domains are primarily αhelical structures. The D2 and D3 domains are composed mainly of β-sheets. The D0 and
D1 domains are essential for the assembly of helical filamentous structures, so they are
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highly conserved in different bacteria species, while the other two domains show a high
degree of sequence diversity. The highly conserved N-terminal and C-terminal D0 and D1
domains of flagellin are crucial for its immunostimulatory function.[24, 31, 32] While the
middle hypervariable D2 and D3 domains are essential for the antigenicity of flagellin and
may cause undesirable toxicity in flagellin‐associated treatments.[33, 34] The D2 and D3
domains have vast diversity in their sequence, size, and composition in different bacterial
strains and are even absent in some bacterial species, such as T pallidum. As an activator
in shaping both innate and adaptive immunity, flagellin as a vaccine carrier protein or a
vaccine adjuvant has been shown to enhance the cross‐protective response of related
antigens against a variety of infectious diseases, and some of the flagellin-related vaccines
are investigated in human preclinical and clinical trials.[35-37] More significantly,
flagellin exhibits anti-tumor, anti-metastatic immunotherapy, and radioprotective
properties through inducing TLR5 pathway activation.[34, 38-40] The flagellum filament
is anchored into the bacterial membrane by a basal body.[41] The filaments, hook, and
basal body together constitute complete flagellar machinery, which allows bacteria to swim
through the rotation of the filaments. Flagella-mediated motility is very important for
bacteria to find nutrients and avoid harmful substances in the environment.
Counterclockwise rotation of the motor provides smooth forward swimming, while
clockwise rotation of some of the flagella causes unraveling of the bundle and specific
tumbling movement.[42] Filaments are much longer than the cell body and during smooth
swimming, they adopt a left-handed supercoiled corkscrew shape, while clockwise rotation
changes the handedness.[43, 44] Flagella is also important in promoting bacterial adhesion
and invasion of host cells.[45] For enteric bacteria, flagella-mediated motility is conducive

4

to the rapid renewal of epithelial cells, the tight intercellular junctions, and the viscous
mucus present in gastrointestinal tissues. For example, Spiral Campylobacter jejuni (a
common cause of gastroenteritis) and Helicobacter pylori (the main pathogen of chronic
gastric ulcer) both have flagella with polarity orientation; mutations that disrupt the flagella
prevent these two bacteria from establishing a replication niche in the gastrointestinal
tract.[46] Other bacterial pathogens such as Pseudomonas aeruginosa and Vibrio cholera
also rely on an intact flagellum for colonization of their hosts, respectively.[47] Flagellated
bacteria support the critical functions of flagella and are the main cause of many serious
skin, soft tissue, lung, and urinary tract infections.

5

Figure 1.1. Organization of flagellum and flagellin. Motile bacteria produce flagella
composed mainly of polymerized flagellin.
Flagellin consists of four domains: the terminal α-helixes (D0), the central α-helixes (D1),
and the hypervariable β-sheets and turns (D2 and D3). The α-helix regions are required for
filament architecture and motility functions.[48]
Reprinted with the permission from publisher. Copyright ©2017, ELSEVIER.
While all flagellin structures known so far exhibit a high degree of structural
similarity in the D0 and D1 region, the structures of the variable regions differ extensively.
The structure of the P. aeruginosa type A FliC lacking the D0 domain showed that the D1
domain highly resembles its counterpart in S. Typhimurium.[49] Conversely, the D2
domain adopts a different fold with two β-sheets and one α-helix between them forming a
less flexible cup-like structure positioned parallel to the D1 domain, instead of pointing
away from it as in Salmonella. In the case of Campylobacter, the variable region of the
6

flagellin FlaA is larger and forms three domains (D2, D3, and D4) (Figure 1.3).[50] The
D2 and D3 domains of the Campylobacter FlaA are structural homologs of each other and
the Pseudomonas FliC D2. D4 is inserted between the C-terminal moieties of D2 and D1,
with most of the FlaA glycans located on this domain. It is the most exposed outer domain
resembling a shield for both D2 and D3 and, in contrast, D4 does not have structural
homologs.

Figure 1.2. The structure of flagellin and the cross-sectional and top views of the flagellar
filament.
The flagellar filament is composed of a single protein, flagellin.
This figure belongs to [51]. © Authors. Publisher: Sci Rep. 2016
License link: https://creativecommons.org/licenses/by-nc-nd/4.0/
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Figure 1.3. Cryo-EM structure of the C. jejuni flagellar filament.
(A) The model of a single C. jejuni flagellin. (B) Comparison between C. jejuni and S.
Typhimurium flagellins. The inner core domains (D0 and D1) are in pink and shown in the
same orientation. The outer domains for C. jejuni (D2, D3, and D4) and S. Typhimurium
(D2 and D3) are shown in cyan.[50]
Reprinted with the permission from publisher. Copyright ©2020, Proc Natl Acad Sci USA.

1.3

Flagellin sensing by immune and non-immune cells
Flagella elicit the activation of host inflammatory responses via flagellin interaction

with specific molecules through a variety of signaling pathways. Flagellin has been
identified as a key virulence factor across pathogenic bacterial genus and species, including
Helicobacter pylori, Pseudomonas aeruginosa, and Vibrio cholerae.[52-54] Deletion of
the gene encoding flagellin in these bacteria greatly impacts the pathogenesis of the
bacterial infection.[52-54] Flagellins act as potent agonists of the innate immune system
inducing proinflammatory responses, given their ability to stimulate the extracellular Toll8

like receptor 5 (TLR5), the intracellular NOD-like receptor (NLR) family 4 (NLRC4)NAIP 5/6 inflammasome, and an unknown additional third pathway recently proposed that
is independent of TLR5, Casp1/11, and MyD88.[55-60] Lack of flagella correlates with a
reduced ability of triggering inflammasome activation in macrophage and reduced
inflammation in mice infection models.[52-54]
1.3.1

Structural interactions between flagellin and TLRs

The Toll-like receptor (TLR) family in the mammalian genome was first described
decades ago as innate immunosensors that recognize evolutionarily conserved PAMPs.[24,
61] Since then, searching for the structural basis of TLRs recognition ligands and
understanding the molecular mechanisms of their activation have become the focus of
many structural biology studies. About 10 years ago, the structures have been reported for
TLR2-TLR1 and TLR2-TLR6 heterodimers in complex with lipopeptides,[62, 63] TLR3
in complex with double-stranded RNA molecule,[64] and TLR4 in complex with MD-2
with or without lipopolysaccharide (LPS).[65, 66] Although TLRs exhibit a conserved
horseshoe-shaped leucine-rich repeats (LRRs) structural fold, the region where each
receptor binds to the ligand depends on the nature of the ligand. The lack of a common
ligand binding mode in the published TLR ligand complexes makes it difficult to predict
the ligand recognition mode of the remaining TLRs. Yoon and his colleagues determined
the ligand complex crystal structure of TLR5, another member of the TLR family, adding
an important clue to how TLR mediates ligand recognition and immune activation.[67]
Human TLR5 recognizes bacterial flagellin, a major component of bacterial motor flagella
found in Gram-positive and Gram-negative bacteria.[55] Flagellin binding leads to the
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accumulation of the cytoplasmic TIR [Toll/Interleukin (IL)-1 receptor] domain of TLR5
and the activation of the MyD88 (myeloid differentiation 88) pathway, which includes the
recruitment of IRAK (IL-1 receptor associated kinase) and TRAF6 (TNF receptorassociated factor 6) and activation of the transcription factor nuclear factor (NF) κB,
leading to the production of the pro-inflammatory cytokine IL-6 (Figure 1.4).[68]

Figure 1.4. Detection of flagellin and TLR5 signaling.
TLR5 utilizes the universal TLR-specific adapter molecule MyD88, which activates
downstream molecules nuclear factor-kB, mitogen-activated protein kinases, and
interferon regulatory factors, which turn on the transcription of genes involved in innate
and adaptive immunity.[48]
Reprinted with the permission from publisher. Copyright ©2017, ELSEVIER.
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The crystallization of TLR receptors has proven to be challenging, mainly due to
poor recombinant expression of the extracellular ligand-binding domain and the low
crystallization tendency of natural TLRs. Two technical strategies were developed for
TLRs crystallization: (i) screening human TLR5 homologues with different extracellular
truncations to find a structure with abundant expression; (ii) fusing the hagfish variable
lymphocyte receptor (VLR) at the C-terminus domain to promote crystallization. Both
techniques had been applied to the structural determination of TLRs.[62] In this case, Yoon
et al. succeeded in expressing several truncated forms of the extracellular domain of TLR5
from zebrafish and validated that a human TLR5 ligand functionally activated zebrafish
TLR5 using a reporter system for transcriptional activation of NF-κB. They crystalized a
construct containing the 14 N-terminal LRRs from zebrafish TLR5 fused to a hagfish VLR
in complex with a fragment of Salmonella flagellin. They also solved the structure of a
shorter construct of the TLR5 alone. The 2.5 Å resolution structure of the TLR5-flagellin
(Salmonella) complex revealed both the unique aspects of ligand binding to TLR5 and the
common dimerization feature shared between TLR5 and other TLRs.[62]
Yoon et al. described how TLR5 forms 2 : 2 dimers with Salmonella flagellin,
similar to TLR4 : MD-2-LPS, but different from the 2:1 dimer observed in TLR1-TLR2:
lipopeptides or TLR3 : dsRNA (double-stranded RNA) complexes. The binding interface
of flagellin in TLR5 is rather extensive and involves the N-terminal and the first 10 LRR
regions. The focal region is centered at the LRR9 loop, which mediates many important
interactions. The LRRs for flagellin binding to TLR5 is different from the LRRs used by
TLR2/1 in lipopeptide binding, which requires the central LRR 9 to 12 repeats, and from
those involves in dsRNA recognition by TLR3, which requires N-terminal to third repeats
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(NT to LRR3) and repeats 19 to 21. Although TLR4 uses similar regions [N-terminal to
fifth repeats (LRR NT to LRR5) and between the eighth and tenth repeats (LRR8-10)] for
MD-2 recognition, the detailed interface residues are different.[66] Therefore, depending
on the ligands, different TLR uses different LRRs to recognize the ligand. This allows a
limited number of TLRs to recognize a diverse collection of ligands. In terms of ligands,
the recognition of TLR5 involves a set of relatively conserved residues among bacteria on
the N-terminal and C-terminal helices in the D1 domain of flagellin. The TLR5 interface
residues of flagellin are usually involved in the formation of bacterial flagellin oligomers
and therefore will not be exposed in live bacteria.[56] Like other TLR-ligand complexes,
the ligand-bound TLR5 forms a symmetric m-shaped dimer. The C-terminal LRR regions
are juxtaposed with each other. This conformation is conducive to the dimerization of the
intracellular TIR domains which will then activate downstream signaling pathways. The
dimer interface induced by flagellin binding involves residues of LRRs 12 and 13 of TLR5.
The authors demonstrated that TLR5 mutants containing mutations at these sites were
unable to transcriptionally activate the NF-κB reporter system in response to flagellin.
Besides TLR5 homodimer, extracellular flagellin binds to the TLR4/5 heterodimer and the
dimerization of their TIR domains recruits adaptor TRIF (TIR-domain-containing adapterinducing interferon-β), which activates the IRF3 pathway, leading to the production of
interferon β.[69]
TLR5 is expressed by epithelial cells, monocytes, and immature dendritic cells.[70,
71] The initial identification of flagellin as a ligand for TLR5 came from a study that used
HPLC to isolate stimulating components from Listeria culture supernatants.[55] Parallel
studies investigating the activation of epithelial cells caused by Salmonella also confirmed
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that flagellin is a stimulating ligand for TLR5.[72] Therefore, TLR5 can recognize the
flagellin produced by gram-negative bacteria and provides a simple strategy for the host
response to flagellar bacteria.
Compared with many other TLR ligands, the proteinaceous nature of flagellin
allows us to study in detail the structural basis of flagellin-TLR5 interaction. Two different
groups have demonstrated that flagellin produces biological activity in eukaryotic
expression systems, demonstrating that the stimulation ability of flagellin is independent
of other bacterial proteins or prokaryotic post-translational modifications.[56, 73] Using
the defined deletion mutants of flagellin, two different groups initially identified two
different sites required for biological activity. The hypervariable region is located in D3
and the conserved N- and C-termini of the protein.[31, 74] This discrepancy was resolved
by more detailed mapping, which defined the TLR5 stimulatory activity in N-terminal
residues 79-117 and 408-439.[56] Therefore, TLR5 is likely to recognize the spatial area
of flagellin, comprising areas of the N- and C-terminus.
The TLR5 binding site of flagellin is likely to be located at the central base of the
flagellum. This observation is interesting because these residues are necessary for the
inherent structure of flagellum and bacterial movement. Therefore, bacteria cannot escape
detection by the host through mutations in the flagellin sequence without compromising
the beneficial aspects of bacterial motility. However, it is currently unclear how the internal
structure of flagellar filaments interacts with TLR5, thereby mediating pro-inflammatory
activity in vivo. One possibility is that monomers or oligomers of flagellin are released
from the filaments in the harsh environment of the phagosome or exposed during bacterial
replication.[75, 76]
13

In addition to TLR5, another recently discovered pattern recognition receptors (PRRs)
present in mice, TLR11, was identified as a receptor of flagellin.[77] The interaction of
flagellin with TLR11 is more restricted compared to its interaction with TLR5. A study by
Hatai et al. [77] shows that TLR5 strongly interacts with flagellin at both acidic and neutral
pH conditions, whereas acidic conditions are essential for TLR11-flagellin interaction.
Furthermore, this study shows that both the N- and C-terminal domains of flagellin can
independently interact with TLR11, whereas the TLR5-flagellin interaction requires both
domains to mediate a proinflammatory cytokine response and thus adjuvant activity.[31]
TLR11 is highly expressed in epithelial cells in various organs, such as the intestine, lung,
and skin, and it has a role in the prevention of Salmonella invasion in mice.[78] This result
contrasts with TLR5-deficient mice, which show enhanced resistance against oral
Salmonella infection.[79] These findings suggest that flagellin-TLR11 signaling
mechanisms differ from flagellin-TLR5 interaction, and therefore, more research are
needed to clarify it.
1.3.2

structural interactions with intracellular receptor NAIP5/6

The cytosolic flagellin is detected through NOD-like receptors (NLR) in mice. Two
of these, NAIP5 and NAIP6, are involved in the interaction with flagellin in the cytosol.
Upon flagellin binding, NAIP5 associates with NLRC4 to form an inflammasome that
activates caspase-1, which, in turn, induces the inflammatory response by cleaving and
activating interleukins IL-1β and IL-18, and triggers the subsequent lytic form of cell death
named pyroptosis.
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In animals, several NLRs have been reported to function as PRRs, detecting
PAMPs or host-derived damage-associated molecular patterns (DAMPs) in the cytosol and
consequently initiating innate immune responses.[25, 80] In mice, the specificity of the
inflammasomes is conferred by NAIPs, with NAIP5/6 and NAIP2 recognizing bacterial
flagellin and the T3SS components, respectively.[21, 59] NAIP1 from mice and its human
ortholog of hNAIP are considered as receptors for T3SS needle proteins.[81, 82] Like
NAIP2/5, NAIP1 and hNAIP form ligand-induced NAIP-NLRC4 inflammasomes for
caspase-1 activation as well. It is suggested that the NBD-associated central domains other
than the LRR of NAIPs are critical for their specific recognition of the bacterial
PAMPs.[83] It has also been reported that the BIRs of NAIP5 are critical for flagellininduced NAIP5-NLRC4 inflammasome activation, although it remains unclear how they
contribute to the activation of NAIP5-NLRC4 inflammasome.[59] Despite the important
roles of NLRs in the detection of the invasion of pathogens in both animals and plants,[84]
the mechanisms of how NLRs detect and interact with pathogen-associated ligands remain
poorly understood.
Structural and mechanistic studies have provided profound insights into the process
of NAIP-NLRC4 inflammasome assembly. (Figure 1.5) In the first step, an activating
ligand (flagellin or T3SS needle or inner rod proteins) interacts with an inactive NAIP
protein and causes a conformational change in the NAIP protein that relieves
autoinhibition. This step is illustrated by the example of the flagellin-NAIP5 interaction:
The structure of the flagellin-NAIP5-NLRC4 inflammasome complex shows that NAIP5
alone interacts with flagellin, making numerous contacts with both helices of the D0
domain.[85] Six different regions of NAIP5 (N-terminal helix, BIR1, HD1, HD2, ID, and
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LRR) form a flagellin-binding pocket and confer ligand specificity. Based on two-hybrid
assays, flagellins from five pathogenic bacteria (L. pneumophila, S. Typhimurium, Y.
enterocolitica, Photorhabdus luminescens, and P. aeruginosa) showed positive results
while those from five others including EPEC, EHEC, Shigella flexneri, Chromobacterium
violaceum, and Burkholderia thailandensis were unable to interact with NAIP5.
Additionally, those flagellins that interacted with NAIP5 also induced inflammasome
activation in bone marrow-derived macrophages. These studies confirmed that the ability
of flagellins to bind NAIP5 correlates with their ability to induce an immune response and
that NLRC4 acts as an adaptor through which inflammasome activation signals generated
from different NAIP receptors are transduced to caspase-1.[59] While structural insights
are lacking for the other ligand-NAIP partners, it is assumed that they proceed via a similar
mechanism of ligand-induced NAIP activation. The recognition of flagellin by NAIP
seems to involve the C-terminal D0 domain of flagellin and later N-terminal D0 domain of
flagellin was proved to contribute to the recognition by NAIP.[86, 87] Mutagenic studies
found that while mutation of these key recognition motifs in the ligand enabled immune
evasion by NAIP5, it also disrupted flagellar motility.[85] As mutations of specific leucine
residues in the C-terminal domain abrogate NAIP5/NLRC4-mediated inflammasome
formation.[87, 88] This observation, coupled with the fact that the membrane-localized
flagellin sensor TLR5 senses a conserved and functionally important site in the D1 domain
of flagellin, limits pathogen immune evasion.[56, 85] Interestingly, while the LRRs has
been proposed to act as a sensor for NLR ligands, studies have revealed that ligand
specificity by NAIPs is mediated by an internal region containing NBD-associated α-
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helices (in particular the helical domain 1 or HD1, winged-helix domain or WHD, and
helical domain 2 or HD2) rather than the LRRs.[83, 89, 90]

Figure 1.5. Structure of the NAIP5-NLRC4 inflammasome.
(A) Schematic of domain architecture for NAIP5 and NLRC4. (B) Proposed events of
inflammasome assembly. The flagellin D0 domain (purple) binds to NAIP5 and unfurls
the protein for subsequent NLRC4 recruitment and activation. Active NLRC4 recruits
further NLRC4 protomers for self-propagating oligomerization and completion of a
caspase-1 recruitment platform.[85]
Reprinted with the permission from publisher. Copyright ©2017, America Association
for the Advancement of Science.

Once a NAIP protein has become activated by its respective ligand, it can interact
with an inactive NLRC4 monomer. The inactive NLRC4 monomer has been structurally
characterized by X-ray crystallography and revealed that an ADP-mediated interaction
between the central NBD and WHD domains stabilized the closed conformation of
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NLRC4.[91] The same study revealed that the C-terminal LRRs were positioned to
sterically occlude one surface of the NBD and sequester NLRC4 in a monomeric state.[91]
The authors also demonstrated that mutagenesis abolishing crucial inhibitory interactions
lead to constitutive NLRC4 inflammasome activation and bypassed the requirement for
flagellin.[91]
Once a ligand-bound NAIP complex interacts with NLRC4, it is sufficient to trigger
conformational changes in NLRC4, driving it toward an active conformation.[85, 92]
Activation of an NLRC4 monomer is mediated by a 90° conformational rotation in the
hinge region between HD1 and WHD. This conformational change exposes a largely basic
“catalytic surface” on the active NLRC4 that can interact with the largely acidic “receptor
surface” on an incoming inactive NLRC4 monomer. This interaction activates the second
NLRC4 monomer, which can recruit additional NLRC4 monomers and leads to a selfpropagation mechanism resulting in the formation of a 10-12 subunit wheel-like
structure.[85, 92] Importantly, NAIPs also possess a “catalytic surface” that matches the
“receptor surface” of NLRC4 and enables initiation of oligomerization, but they do not
possess a "receptor surface" and therefore only a single NAIP is found per NAIP-NLRC4
inflammasome complex.[85, 92] Unlike apoptosome oligomerization, which requires one
cytochrome c ligand per APAF-1 monomer, the NAIP-NLRC4 inflammasome only
requires a single bound ligand to initiate oligomerization.[93] This point of difference
suggests that the NAIP-NLRC4 inflammasome can respond to a lower concentration of
activating ligand and that different cell death pathways have different thresholds for
initiation.
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1.3.3

The third potential pathway

It was recently reported that with the absence of TLR5, the inflammasome, and
MyD88, flagellin can induce potent IgG1 anti-flagellin responses. Based on this
observation, a third pathway that promotes anti-flagellin antibodies production was
proposed, independent of TLR5 and inflammasome, and requiring the presence of all four
domains of flagellin. Nempont et al. illustrated different flagellin domain deletions that had
reduced immunogenicity and indicated that the D2/D3 domains may be the most critical
for MyD88-independent IgG1 anti-flagellin responses.[94] Mice immunized with flagellin
and different truncated versions made antibodies that showed reactivity to the D0/D1 and
D2/D3 domains, indicating that both components of the molecule are antigenic. The D3
domain of flagellin influences immunogenicity independently of the known innate
recognition sites in the D0/D1 domains to augment antibody production, suggesting that
full-length flagellin and the preservation of all four domains were critical for optimal
immunogenicity and primary and secondary antibody responses in flagellin-based
vaccines.[60] The nature of the third pathway is poorly understood and requires further
investigation.

1.4

Pro-inflammatory activity of flagellin
Preliminary studies with human blood mononuclear cells have shown that flagellin

from different bacteria species can stimulate the production of cytokines, such as TNF-α
and IL-1β.[75, 95] In addition, the flagellin produced by Salmonella typhi can induce the
synthesis of IL-6 and the anti-inflammatory cytokine IL-10.[75, 95-97]
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Recent studies by Gewirtz et al. determined that Salmonella flagellin stimulates the
production of IL-8 when exposed to human intestinal epithelial cells.[98] Interestingly, the
activation of this inflammatory response depends on the transfer of flagellin to the
basolateral surface of epithelial cells, where TLR5 is expressed.[72, 98] Other researchers
have tested the activation of human intestinal epithelial cell lines by flagellin and noted the
production of the chemokine CCL-20 and subsequent migration of immature human
dendritic cells (DCs) under this stimulus.[99] It was suggested in this report that the apical
expression of TLR5 is related to the secretion of chemokines.[99] Consistent with this
view, TLR5 is constitutively expressed on the top surface of human primary intestinal
epithelial cells (IECs), and another recent study has shown that flagellin from commensal
bacteria can induce TLR5 activation on the apical surface of freshly isolated murine
IECs.[70, 100] Further research is needed to solve the problem of TLR5 expression on the
surface of epithelial cells and flagellin translocation. If TLR5 is expressed on the apical
surface of epithelial cells, why flagellar symbiotic bacteria cannot induce a permanent
inflammatory state in the intestinal mucosa is still unclear. One possibility is that symbiotic
microorganisms can also induce anti-inflammatory signaling pathways in epithelial
cells.[101, 102]
TLR5 is also highly expressed in the lungs and seems to play an important role in
combating respiratory pathogens.[103-105] Interestingly, there is a correlation between
common human TLR5 polymorphisms and susceptibility to Legionnaires disease.[106] A
single point mutation to a stop codon at position 392 resulted in an impaired response to
flagellin in these patients.[106] In summary, the existing evidence shows that the
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expression of TLR5 in the intestinal mucosa and respiratory mucosa is an important innate
immunosensor for flagellate pathogens.

1.5

Flagellin and inflammatory disease
Flagellin can induce the expression of a variety of pro-inflammatory mediators,

such as TNF-α, IL-1, IL-6, MIP-3a, and iNOS, so it is likely involved in the development
of bacterial-related pathology. (Figure 1.6) To support this hypothesis, direct instillation
of 1 μg of flagellin into the mouse trachea caused acute inflammation in the lungs,
including infiltration of neutrophils and macrophages, and presence of inflammatory
cytokines in bronchoalveolar lavage fluid (BAL).[107] Surprisingly, flagellin is more
effective than lipopolysaccharide in the induction of lung inflammation, which may be due
to lower levels of TLR4 in the lung, as compared in the intestinal epithelium.[70, 107]
Therefore, the chronic lung pathology caused by flagellar pathogens such as Pseudomonas
or Legionella may be partly due to the host response to flagellin.[105, 106]
Similar to endotoxin, flagellin is an effective mediator of systemic inflammation.
Intravenous injection of flagellin in mice can rapidly produce typical cytokines,
chemokines, and NO production, and can cause clinical symptoms such as septic shock,
hypotension, respiratory distress, cyanosis, organ damage, and death.[76, 108] For LPS
and flagellin induced infection, although it is not clear which one is more effective in
causing toxic shock in mice, these data suggest that flagellin may be an important factor in
the inflammatory process of bacterial sepsis.[76, 108, 109]
Inflammasome is a large cytoplasmic complex that can sense microbial
infections/dangerous molecules and induce the production of caspase-1 activation21

dependent cytokines and the inflammatory death of macrophages.[110] The inflammasome
assembled by the NOD-like receptor (NLR) protein NLRC4 responds to bacterial flagellin
and a conserved type III secretion system (T3SS) rod component.[111-113] Certain
bacteria such as S. typhimurium can directly deliver flagellin into the cytoplasm of host
cells through T3SS.[114, 115] Another route of flagellin entry into cytoplasm is
endocytosis. How the NLRC4 inflammasome detects the two bacterial products and the
molecular mechanism of NLRC4 inflammasome activation are not understood. It is
reported that NAIP5, a BIR-domain NLR protein required for Legionella pneumophila
replication in mouse macrophages, is a universal component of the flagellin-NLRC4
pathway.[21, 59, 87, 116, 117] The binding of flagellin to NAIP5 promotes the physical
binding of NAIP5-NLRC4 and completely reconstructs the flagellin-responsive NLRC4
inflammasome in non-macrophage cells.[59] This finding further indicates that the
remaining NAIP family members may recognize other unidentified microbial products to
activate NLRC4 inflammasome-mediated innate immunity.
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Figure 1.6. Signal transduction by flagellin in mammalian cells.
Immune cells respond to extracellular monomeric flagellin through either TLR5
homodimer or heterodimer complexes, resulting in the transcription of a variety of genes
that are important for the proper stimulation of immune cells. The intracellular flagellin is
detected by NAIP5/6 which recruits and phosphorylates NLRC4, which induces caspase1 activation and subsequent pyroptosis.
This figure belongs to [118]. © Authors. Publisher: Exp Mol Med. 2017
License link: https://creativecommons.org/licenses/by-nc-nd/4.0/
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CHAPTER 2. BACTERIAL FLAGELLIN INDUCED IL-6 AND TNFΑ RELEASE IN VIVO
DEPENDS ON INFLAMMASOME ACTIVATION AND PYROPTOSIS

2.1

Introduction
As we mentioned previously, cytokine storm is a massive and sudden production of

inflammatory cytokines, and it has been associated frequently with detrimental clinical
outcomes. Flagellin as a common virulence factor which can induce inflammation was
used to explore the mechanism of cytokine generation and release in vivo in this study.
We used flagellin from L. pneumophila to investigate flagellin-induced inflammation
in vivo. Flagellin was fused to the cytosolic translocation domain of anthrax lethal factor
(LFn) to enable efficient cytosolic delivery. LFn binds to anthrax protein protective antigen
(PA), which delivers LFn-flagellin fusion protein into cytoplasm through receptormediated endocytosis.[59] We found that flagellin-induced release of the pro-inflammatory
cytokines in vivo depends on inflammasome activation and pyroptosis. Deficiency of the
flagellin intracellular receptor NAIPs, caspase-1, or GSDMD, but not the cell surface
receptor TLR5, abolished LFn-flagellin/PA induced cytokines. Depletion of macrophages
and monocytes by clodronate significantly reduced LFn-flagellin/PA induced cytokine
release. Our findings illustrate the important role of inflammasome activation and
pyroptosis in inflammation during bacterial infection.
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2.2

Material and methods
2.2.1

Mice.

Wild-type C57BL/6J, Naip-/-, Casp1-/-, Tlr4-/-, Tlr5-/-, Gsdmd-/-, mice were housed
in the University of Kentucky Animal Care Facility, following institutional and National
Institutes of Health guidelines after approval by the Institutional Animal Care and Use
Committee. Male mice at 8-12 weeks were used in all experiments.

2.2.2

LFn fusion protein expression and purification

As described previously,[119] proteins were expressed using LPS free E. coli strain
ClearColi BL21(DE3) (Lucigen Corporation, Cat#60810) at 37 °C for 4 hours with 500
μM IPTG after OD600 reached 0.6-0.8. Bacteria were collected and lysed in 50 mM TrisHCL and 300 mM NaCl. Proteins containing a His-tag were purified by affinity
chromatography using HisPur Ni-NTA resin (Thermo scientific, Cat#88222). Proteins
were then eluted with 250 mM imidazole in 50 mM Tris-HCL and 300 mM NaCl, and
subsequently dialyzed against PBS to remove imidazole. Protein concentrations were
determined by measuring their absorption at 280 nm before sterile filtration.

2.2.3

In vivo study

C57BL6 and the corresponding gene deficient mice caspase 1-/-, Tlr4-/-, Tlr5-/-,
Gsdmd-/- and Naip-/- (10-12 weeks old) were injected with 3 μg of LFn-fla with or without
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PA, or 1.5 μg of LFn-EprJ with or without PA, as indicated. Blood samples were collected
before or at various time (90 min, 4 h, and 8 h) following injection of the bacterial proteins.
To determine the inflammasome activation, blood samples were collected via retro-orbital
bleeding. Blood samples were centrifuged at 10,000 g for 1 minute at room temperature to
obtain plasma. IL-1β, IL-6, and TNFα were measured using ELISA following
manufacturer’s instruction.

2.2.4

Monocytes/macrophage depletion

To deplete monocytes/macrophages, C57BL6 mice were injected intravenously
with 40 mg/kg of clodronate-loaded liposome suspension (Encapsula NanoSciences,
Nashville, TN) 24 hours prior to injection with LFn-fla/PA. Control mice were injected
with PBS-loaded liposomes instead.

2.2.5

IL-1R blocking experiment

C57BL6 mice were injected intravenously with 1 mg/kg of recombinant human IL1 receptor antagonist (IL-1RA, PeproTech, Cat# 200-01RA) 10 min before the injection
with 3 μg of LFn-fla and 3 μg of PA. Blood samples were collected before or at various
time points (90 min, 4 h, and 8 h) after the injection with LFn-fla/PA.
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2.2.6

Bone marrow derived macrophage (BMDM) culture and stimulation

BMDMs were prepared as described previously,[120] and seeded into 12-well cell
culture plate (1 mL/well) or 96-well cell culture plate (100 µL/well) at a density of 1 x 106
cells/mL of RPMI-1640 medium containing 15% L929-cell conditioned medium (LCM).
BMDMs were allowed to settle overnight and refreshed with Opti-MEM (Life
Technologies, Cat#31985-070) before purified protein were added. For study of cytokine
release, supernatant samples were collected 6 h after stimulation. For study of cytotoxicity,
supernatant samples were collected 90 min after stimulation.

2.2.7

Peritoneal macrophage culture and stimulation

Peritoneal macrophages were harvested from C57BL/6J and Tlr4-/- mice following
the protocol published by Zhang et al.[121] Cells were seeded into a 96-well cell culture
plate at a density of 1×106 cells/ml in DMEM/F12 medium supplemented with 10 mM Lglutamine, 100 IU/ml penicillin, 100 μg/ml streptomycin, and 10% (v/v) fetal bovine serum
(FBS). Peritoneal macrophages were allowed to settle overnight and refreshed with 100 μL
of Opti-MEM before purified proteins were added (LFn-Fla with or without PA at 1 μg/ml
each, or LPS 200 ng/mL). For study of flagellin induced cytokine release, the supernatants
were collected 6 h after stimulation.
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2.2.8

Kupffer cell isolation, culture, and stimulation

Kupffer cells were isolated from C57BL/6J and Tlr4-/- mice following the protocol
published by Zeng et al.[122] Cells were cultured on a 10 cm cell culture dish in DMEM
supplement with 10 mM L-glutamine, 100 IU/ml penicillin, and 100 μg/ml streptomycin,
and 10% (v/v) FBS at 37 ℃. The culture medium was then changed every two days until
the cells reached 80% confluence. The cells were then seeded into a 96-well cell culture
plate at a density of 1×106 cells/ml of culture medium. Kupffer cells were allowed to settle
overnight and refreshed with 100μL of Opti-MEM before the indicated proteins were
added.

2.2.9

Monocytes isolation and stimulation

Monocytes were isolated from C57BL/6J and Tlr4-/- mice using the Monocytes
Isolation Kit (BM) (Miltenyi Biotec, cat# 130-100-629). The isolated cells were seeded
into a 96-well cell culture plate at a density of 1×106 cells/ml in DMEM medium
supplemented with 10 mM L-glutamine, 100 IU/ml penicillin, 100 μg/ml streptomycin,
and 10% (v/v) fetal bovine serum (FBS). Monocytes were allowed to settle for 2 hours and
refreshed with 100 μL of Opti-MEM before purified proteins were added (LFn-Fla with or
without PA at 1 μg/ml each). For study of flagellin induced cytokine release, the
supernatants were collected 6 h after stimulation.
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2.2.10 ELISA analysis

To determine IL-1β, IL-6, and TNFα cytokine levels in culture supernatants,
ELISAs were performed using the mouse IL-1β, IL-6, and TNFα Invitrogen ELISA kits
from ThermoFisher Scientific. ELISA assays were performed according to manufacturer
instructions. To determine IL-1β, IL-6, and TNFα levels, supernatants or plasma samples
were diluted appropriately. Plates were read on a Cytation 5 at 450 and 580 nm. Cytokine
concentration was determined by extrapolation from the standard curve.

2.2.11 Lactate dehydrogenase cytotoxicity assay

To determine cell viability, the lactate dehydrogenase (LDH) CytoTox 96 NonRadioactive Cytotoxicity Assay kit (Promega, Cat#G1780) was used. 50 μl of CytoTox 96
Reagent was added to each well of 96-well plate followed by 50 μl of supernatant samples
and incubate for 10min at room temperature or until a sufficient colorimetric change was
visible. The reaction was stopped using the LDH stop solution, and the plate was read on
a Cytation 5 at 490 nm.

2.2.12 Western blotting

For detection of active caspase-1 and IL-1β cleavage by western blotting, cells were
washed with cold PBS and lysed with an SDS sample buffer. Culture supernatants were
precipitated with 1/10 volume of 2% sodium cholate and 1/10 volume of 100%
trichloroacetic acid (TCA), and then dissolved in the SDS sample buffer. Total protein
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from lysates and supernatants (equivalent to 1 ×10 cells) was analyzed by western blotting
for multiplex detection. Both pro-caspase-1 and p20 caspase-1 were determined using anticaspase-1(p20) (Adipogen, Cat#AG-20B-0042) at 1:1000 dilution. Pro-IL-1β and IL-1β
(p17) was detected using anti-IL-1β (GeneTex Cat#GTX74034) at 1:1000 dilution. Blots
were imaged using BIO-RAD ChemiDoc MP imaging system.

2.2.13 Statistical analysis

Statistical analysis was performed in Prism GraphPad 9.0.0. Statistical analysis was
performed using one-way ANOVA with Dunnett’s multiple comparisons for multiple
groups and two-way ANOVA repeated measures with Holm-Sidak multiple comparisons
for time point studies. A p value <0.05 was considered significant.

2.3

Results

2.3.1

Injection of LFn-fla together with PA, but not LFn-fla alone, increased plasma
TNFα, IL-6 and IL-1β concentrations

Flagellin induces cytokine production through its receptors TLR5 and NAIPs.
While induction of IL-1β release by flagellin requires caspase-1 activation, previous in
vitro studies have shown that flagellin mediates TNFα and IL-6 release through TLR5 in
vitro.[123-128] We used mouse models to investigate the mechanism by which flagellin
induces inflammation in vivo. Recombinant flagellin of L. pneumophila was fused to LFn
to create LFn-fla. C57BL/6J mice were injected with LFn-fla with or without PA by i.v.,
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and blood was collected at various time points thereafter. Cytokine concentrations in
plasma were measured using ELISA assays. Surprisingly, injection of LFn-fla alone into
C57BL/6J mice did not increase plasma concentrations of TNFα and IL-6 (Figure 2.1AC). In contrast, injection of LFn-fla plus PA dramatically increased plasma concentrations
of these cytokines, as well as IL-1β (Figure 2.1A-C). These data suggest that
inflammasome activation mediates flagellin-induced inflammation in vivo.

Figure 2.1. Administration of LFn-fla/PA, but not LFn-fla alone, induced proinflammatory
cytokine release.
(A-C) C57BL/6J mice were injected intravenously with LFn-fla (3 μg) or LFn-fl plus PA
(3 μg). Blood samples were collected right before and at 90 min, 4 h, 8 h after injection.
IL-1β (A), IL-6 (B), and TNFα (C) concentrations in plasma were measured by ELISA
assay. Error bars denote SEM, n=4 for each group. One asterisk, p<0.05; two asterisks, P
< 0.01; three asterisks, P<0.001; two-way ANOVA with Holm-Sidak multiple
comparisons.

2.3.2

Deficiency of NAIPs but not TLR5 protected against flagellin-induced
inflammation

To verify that inflammasome activation is responsible for flagellin-induced
inflammation in vivo, we examined LFn-fla/PA induced cytokine release in mice deficient
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of the flagellin intracellular receptor NAIPs. While humans have only one subtype of
NAIP, mice have 6 subtypes of NAIPs (NAIP1-6) that respond to different kinds of
PAMPs.[59] We used a mouse model in which all NAIPs are deleted.[129] Injection of
LFn-fla plus PA did not significantly increase plasma concentrations of TNFα, IL-6, and
IL-1β in the NAIP deficient mice (Figure 2.2A-C). In contrast, LFn-fla/PA induced release
of the proinflammatory cytokines in the TLR5 deficient mice to levels similar as in the WT
mice. These data demonstrate that inflammasome activation, but not TLR5, is responsible
for flagellin-induced inflammation in vivo.
It has been reported previously that while the flagellins from S. typhimurium, Y.
enterocolitica, and P. aeruginosa could bind to NAIP5 and activate NLRC4
inflammasome, those from enteropathogenic E. coli, enterohaemorrhagic E. coli, Shigella
flexneri, and Burkholderia thailandensis could not interact with NAIP5 and were unable to
activate inflammasome NLRC4.[59] To further test whether flagellin induces
inflammation in vivo dependent on inflammasome activation, we purified LFn fusion of
flagellins from P. aeruginosa and enterohaemorrhagic E. coli. As expected, LFn-flagellin
containing P. aeruginosa flagellin induced pyroptosis of wild-type mouse BMDMs as
evident by release of LDH into the supernatant, and caspase-1 activation and IL-1β
cleavage (Figure 2.2D-F). In contrast, flagellin from enterohaemorrhagic E. coli failed to
induce pyroptosis of BMDMs, caspase-1 activation or IL-1β cleavage (Figure 2.2D-F).
Injection of LFn-Flagellin from P. aeruginosa, but not the flagellin from
enterohaemorrhagic E. coli, in the presence of PA, increased plasma concentrations of
TNFα, IL-6, and IL-1β in C57BL/6J mice (Figure 2.2G-I). Taken together, these data
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suggest that inflammasome activation, but not TLR5, mediates flagellin-induced
inflammation in vivo.

Figure 2.2. Flagellin induced cytokine release in vivo depended on its intracellular receptor
NAIPs, but not TLR5.
(A-C) C57BL/6J (WT), Naip 5-/-, or Tlr 5-/- mice were injected intravenously with LFnFla/PA (3 μg each). Blood samples were collected right before and at 90 min, 4 h, and 8 h
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after injection. IL-1β (A), IL-6 (B), and TNFα (C) concentrations in plasma were measured
by ELISA assay (n=4 for each experimental group). (D-F) BMDMs from C57BL/6J WT
were incubated with 1 μg/ml of LFn fused flagellin from P. aeruginosa or E. coli with PA
for 90 min. Cell viability (D) was assessed by measuring LDH release into supernatant,
and caspase-1 activation (E) and IL-1β cleavage (F) were detected by western blot. (G-I)
C57BL/6J mice were injected intravenously with LFn-fla from P. aeruginosa or E. coli
with PA (n=5 for all experimental group). Error bars denote SEM. One asterisk, p<0.05;
two asterisks, P < 0.01; three asterisks, P<0.001; two-way ANOVA with Holm-Sidak
multiple comparisons. ### p < 0.001, one-way ANOVA with Dunnett’s multiple
comparisons.

2.3.3

LFn-fla/PA-induced cytokine release depended on caspase-1 and GSDMD

In consistent with results from the NAIP deficient mice, LFn-fla/PA-induced
cytokine release was abolished in the caspase-1 deficient mice (Figure 2.3A-C). Flagellin
induces pyroptosis through GSDMD-dependent pore formation on cell membrane.[130132] To determine whether flagellin induces inflammation through pyroptosis, we injected
GSDMD deficient mice with LFn-fla plus PA, and monitored cytokine concentrations in
these mice. LFn-fla/PA-induced cytokine release was significantly reduced in the GSDMD
deficient mice (Figure 2.3A-C). These data indicate that pyroptosis following
inflammasome activation is responsible for LFn-fla/PA-induced cytokine release in vivo.
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Figure 2.3. Caspase 1 and GSDMD dependent pyroptosis is essential to LFn-Fla/PAinduced IL-1β (A), IL-6 (B), and TNFα (C) release.
(A-C) C57BL/6J (WT), Caspase 1-/-, Gsdmd-/- mice were injected intravenously with LFnFla/PA (3 μg each). Blood samples were collected right before and at 90 min, 4 h, and 8 h
after injection. IL-1β (A), IL-6 (B), and TNFα (C) concentrations in plasma were measured
by ELISA assay (n=4 for each group). Error bars denote SEM. one asterisk, p<0.05; two
asterisks, P < 0.01; three asterisks, P<0.001; two-way ANOVA with Holm-Sidak multiple
comparisons.
2.3.4

Depletion of monocytes/macrophages by chlodronate significantly reduced
flagellin-induced TNFα release

Monocytes and macrophages are major sources of TNFα in vivo.[120] To
determine whether monocytes and macrophages are the major sources of LFn-fla/PAinduced TNFα release, we depleted monocytes and macrophages by pre-treating mice with
clodronate following published protocol.[120] Depletion of monocytes and macrophages
indeed dramatically reduced LFn-fla/PA-induced TNFα release (Figure 2.4A-C).
Depletion of monocytes and macrophages also significantly reduced LFn-fla/PA-induced
IL-6 and IL-1β release.
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Figure

2.4.

LFn-Fla/PA-induced

cytokine

release

in

vivo

required

macrophages/monocytes.
C57BL/6J mice were injected intravenously with control liposomes (Lipo) or clodronatecontaining liposomes (Cldn) were given 24 hours prior to intravenous injection of LFnFla/PA (3 μg each). Mice (C57BL/6J with or without macrophage depletion) were orbital
sinus injected with LFn-Fla/PA (3 μg each). Blood samples were collected right before and
at 90 min, 4 h, and 8 h after injection. IL-1β (A), IL-6 (B), and TNFα (C) concentrations
in plasma were measured by ELISA assay (n=4 for each group). Error bars denote SEM.
One asterisk, p<0.05; two asterisks, P < 0.01; three asterisks, P<0.001; two-way ANOVA
with Holm-Sidak multiple comparisons.
2.3.5

LFn-EprJ/PA induced pro-inflammatory cytokine release in mice was
inflammasome activation dependent

Flagellin and conserved type III secretion system (T3SS) rod components of the
Gram-negative bacteria are potent activators of NLRC4.[59, 113] To determine whether
inflammasome activation is a common mechanism for cytokine release, C57BL/6J mice
were challenged with the E. coli T3SS rod protein EprJ, which is a potent activator of the
NLRC4 inflammasome. Injection of LFn-EprJ plus PA, but not LFn-EprJ alone, increased
plasma concentrations of IL-1β, IL-6, and TNFα (Figure 2.5A-C). It has been reported that
EprJ can induce caspase-1 dependent inflammasome activation and pyroptosis.[119] LFnEprJ/PA-induced cytokine release was abolished in caspase-1 deficient mice, and also
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significantly reduced in the GSDMD deficient mice (Figure 2.5D-F). Thus, EprJ-induced
IL-1β, IL-6, and TNFα release depends on inflammasome activation and pyroptosis. These
data demonstrate that inflammasome activation in vivo induces release of multiple
proinflammatory cytokines through direct or indirect mechanisms.

Figure 2.5. E. coli T3SS rod protein EprJ induced proinflammatory cytokine release in vivo
through inflammasome activation.
(A-C) C57BL/6J mice were injected intravenously with LFn-EprJ (1.5 μg) and LFn-EprJ
plus PA (1.5 μg), respectively. Blood samples were collected right before and at 90 min, 4
h, and 8 h after injection. IL-1β (A), IL-6 (B), and TNFα (C) concentrations in plasma were
measured by ELISA assay (n=3 for each group). (D-F) C57BL/6J (WT), Caspase 1-/-,
Gsdmd-/- mice were injected intravenously with LFn-EprJ (1.5 μg) and LFn-EprJ plus PA
(1.5 μg), respectively. Blood samples were collected right before and at 90 min, 4 h, and 8
h after injection. IL-1β (D), IL-6 (E), and TNFα (F) concentrations in plasma were
measured by ELISA assay (n=4 for each group). Error bars denote SEM. One asterisk,
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p<0.05; two asterisks, P < 0.01; three asterisks, P<0.001; two-way ANOVA with HolmSidak multiple comparisons.

2.3.6

LFn-fla/PA induced IL-6 and TNFα release in TLR4 deficient mice in vivo but
not in macrophages isolated from TLR4 deficient mice in vitro

LPS can induce cytokine production through a TLR4-dependent mechanism.[133]
Therefore, both LFn-fla and PA utilized was purified from the ClearColi E. coli strain,
which produces a mutant form of LPS that does not trigger the endotoxic response to
minimize the potential effect from LPS.[134] In addition, we used TLR4 deficient mice to
further exclude the possible effect of LPS contamination. We verified that injection of LFnfla/PA into TLR4 deficient mice induced release of IL-1β, IL-6, and TNFα (Figure 2.6AC). As expected, incubation of TLR4 deficient BMDMs with LFn-fla/PA induced IL-1β
release (Figure 2.6D). However, LFn-fla/PA failed to induce IL-6 and TNFα release in the
TLR4 deficient BMDMs (Figure 2.6E, F). We also tested primary macrophages from
peritoneal cavity and liver. LFn-fla/PA failed to induce IL-6 and TNFα release in these
primary macrophages either (Figure 2.7). Since depletion of macrophages and monocytes
by clodronate drastically reduced LFn-fla/PA-induced IL-6 and TNFα release, we
examined whether monocytes might be responsible for the cytokine production. LFnfla/PA failed to induce IL-1β, IL-6, and TNFα release from monocytes (Figure 2.8).
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Figure 2.6. LFn-Fla/PA induced proinflammatory IL-6 and TNFα release in vivo, but not
in vitro.
(A-C) C57BL/6J WT or Tlr 4-/- mice were injected intravenously with LFn-fla/PA (3 μg
each). Blood samples were collected right before and at 90 min, 4 h, and 8 h after injection.
IL-1β (A), IL-6 (B), and TNFα (C) concentrations in plasma were measured by ELISA
assay (n=4 for each group). Error bars denote SEM. One asterisk, p<0.05; two asterisks, P
< 0.01; three asterisks, P<0.001; two-way ANOVA with Holm-Sidak multiple
comparisons. (D-F) BMDMs from TLR4 deficient mice were incubated with LPS (200
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ng/ml), PA (1 μg/ml), LFn-fla (1 μg/ml), and LFn-fla plus PA, respectively. Concentrations
of IL-1β (D), IL-6 (E), and TNFα (F) in supernatant were measured at 6 hours posttreatment. Mean with SD of three independent experiments (three replicates) are shown.
(G-I) C57BL/6J mice were injected intravenously with IL-1RA (1 mg/kg body weight) 10
min prior to intravenous injection of LFn-Fla/PA (3 μg each). Blood samples were
collected right before and at 90 min, 4 h, and 8 h after injection. IL-1β (G), IL-6 (H), and
TNFα (I) concentrations in plasma were measured by ELISA assay (n=4 for each group).
Error bars denote SEM. One asterisk, p<0.05; two asterisks, P < 0.01; three asterisks,
P<0.001; two-way ANOVA with Holm-Sidak multiple comparisons.
2.3.7

LFn-fla/PA induced IL-6 and TNFα release was not inhibited by IL-1β receptor
antagonist

Inflammasome activation leads to production and release of IL-1β and IL-18. It is known
that IL-1β induces IL-6 and TNFα production and release in mice.[135, 136] Thus, we
investigated whether LFn-fla/PA-induced IL-6 and TNFα release downstream of IL-1β. If
that is the case, pretreatment of mice with the IL-1β receptor antagonist should inhibit IL6 and TNFα release. We found pretreatment of mice with the IL-1β receptor antagonist did
not significantly reduce the plasma concentrations of IL-6 and TNFα following LFn-fla/PA
injection (Figure 2.6G-I).
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Figure 2.7. LFn-fla/PA failed to induce IL-6 and TNFα release in primary Tlr4-/macrophages.
(A-C) Peritoneal macrophages isolated from Tlr4-/- mice were incubated with LPS (200
ng/ml), PA (1 μg/ml), LFn-fla PA (1 μg/ml), and LFn-fla/PA, respectively for 6 h.
Concentrations of IL-1β, IL-6, and TNFα in the supernatant were measured by ELISA
assays. (D-F) Kupffer cells isolated from Tlr4-/- mice were incubated with LPS (200
ng/ml), PA (1 μg/ml), LFn-fla PA (1 μg/ml), and LFn-fla/PA, respectively for 6 h.
Concentrations of IL-1β, IL-6, and TNFα in the supernatant were measured by ELISA
assays at 6 hours post-treatment. Mean with SD of three independent experiments (three
replicates) are shown.

41

Figure 2.8. LFn-fla/PA failed to induce IL-6 and TNFα release in Tlr4-/- monocytes.
(A-C) Monocytes from isolated from Tlr4-/- mice were incubated with with LPS (200
ng/ml), PA (1 μg/ml), LFn-fla PA (1 μg/ml), and LFn-fla/PA, respectively for 6 h.
Concentrations of IL-1β (A), IL-6 (B), and TNFα (C) in supernatant were measured at 6
hours post-treatment. Mean with SD of three independent experiments (three replicates)
are shown.
2.4

Discussion
Flagellin is a potent activator of a broad range of cell types involved in innate and

adaptive immunity. It is a potent inducer of cytokine production in a human promonocytic
cell line, reaching maximal activity at the sub-nanomolar range.[96] Several studies
established TLR5 as the receptor for extracellular flagellin.[55, 72, 137] When flagellin is
present intracellularly, it signals via NAIP5 and NLRC4.[87, 111, 112] In our study,
extracellular flagellin cannot induce proinflammatory cytokine release in mice in vivo, nor
in macrophages in vitro. Generation and release of cytokines into blood in vivo was only
observed when flagellin was translocated into the cytosol via PA/LFn mediated uptake.
Consistent with this observation, deficiency of TLR5 did not influence plasma cytokine
level upon treatment with LFn-fla/PA. In contrast, deficiency of pyroptosis-related genes
including naips, caspase 1, and Gsdmd abolished the release of IL-1β, IL-6, and TNFα,
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suggesting that flagellin induces proinflammatory cytokine release through inflammasome
activation and pyroptosis. Experiments with another virulence factor, the T3SS inner rod
protein EprJ from E. coli, support the idea that cytokine secretion depends on
inflammasome activation and pyroptosis. To our best knowledge, no extracellular receptor
has been reported for EprJ. LFn-EprJ/PA could lead to increased plasma cytokine
concentrations in C57BL/6J mice but not in caspase 1 or GSDMD deficient mice. Two
cytokines, IL-1β and IL-18, are generated directly from inflammasome activation. Our data
indicate that inflammasome activation in vivo results in release of multiple
proinflammatory cytokines including IL-6 and TNFα that are known to play important
roles in the pathogenesis of infectious disease, thereby establish inflammasome activation
and subsequent pyroptosis as an essential mechanism contributing to cytokine storm during
infection.
Cytokines play critical roles in orchestrating a rapid and effective response of
leukocytes and parenchymal cells upon detection of microorganisms or stress signals. The
major acute innate cytokines, IL-1, TNF-α, IL-6, are used to activate endothelial cells and
tissue leukocytes locally, triggering cytokine-mediated amplification loops to promote
chemokine release and endothelial cell adhesion molecule expression, slowing down blood
flow, and increasing vascular permeability.[138] A cohort of cytokines (IL-1, IL-6, and
TNF-α) are released to prepare the organism for defense against pathogens by initiating the
acute response syndrome and to recruit antigen-presenting cells (APCs) to initiate adaptive
immunity.[139]
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As innate immune cells, both monocytes and macrophages are critical for host
defense against pathogens. Monocytes circulate in the blood and spleen. Once recruited to
tissues, monocytes can differentiate into macrophages.[140] Both cells are capable of
phagocytose, secreting chemokines, and proliferating and recruiting other immune cells in
response to infection.[141] Depletion of monocytes and macrophages dramatically reduced
flagellin-induced cytokine release. Although our data did not prove that monocytes and
macrophages are the primary sources of these cytokines, they indicate that pyroptosis of
monocytes and/or macrophages is required for the generation and release of these cytokines
in vivo. The plasma levels of IL-1β and TNFα peaked at a similar time (90 min after
treatment), while IL-6 peaked later (4 h after treatment). IL-1β has been shown to trigger
the generation of other cytokines in vivo, and IL-1 and TNFα mutually stimulate the
production of each other.[135, 136] In our study, we found IL-6 and TNFα secretion are
not IL-1 dependent since blocking of IL-1 receptor did not influence the plasma level of
IL-6 and TNFα, indicating that flagellin induces pro-inflammatory cytokines secretion
through inflammasome activation and pyroptosis, not as a secondary effect mediated by
IL-1.
Our results indicate that flagellin-induced IL-1β, IL-6, and TNFα release in vivo
depends on inflammasome activation and subsequent pyroptosis. However, the origin of
pro-inflammatory cytokines remains elusive. LFn-fla/PA induced IL-1β release from
mouse BMDMs or primary macrophages, suggesting that macrophages as a major source
of IL-1β release in vivo following inflammasome activation. Since LFn-fla/PA could not
induce IL-6 or TNFα secretion in mouse BMDMs in vitro, nor in primary macrophages or
monocytes, it is not clear whether macrophages/monocytes are the major sources of these
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cytokines in vivo and if so, that release of these cytokines may require specific in vivo
environment. Alternatively, these cytokines could be generated by other type of cells
downstream of macrophage/monocyte pyroptosis. In this regard, it is known that many cell
types can produce IL-6.[142] Although TNFα was thought to be produced primarily
by macrophages,[143] it could also be produced by a broad variety of cell types
including lymphoid cells, mast

cells, endothelial

cells, cardiac

myocytes, adipose

tissue, fibroblasts, and neurons.[144] Additional studies are necessary to elucidate the
origin and mechanism of pro-inflammatory cytokine production, which may provide new
method to intercept cytokine storm and related diseases. Nevertheless, our study has shed
light on how flagellin as an important virulence factor binds inflammasome receptors and
initiates vigorous proinflammatory response through a previously unrecognized
mechanism in mouse model, establishing novel therapeutic targets.
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CHAPTER 3. STRUCTURE BASIS OF FLAGELLIN INDUCED INFLAMMASOME ACTIVATION

3.1

Introduction
As discussed in chapter 1, flagellin D0 and D1 domain are essential for the

recognition by its extracellular and intracellular receptors. Structural and mechanistic
studies have provided profound insights into the process of NAIP-NLRC4 inflammasome
assembly. However, how flagellin is recognized by NAIPs remains unclear. In this study,
we used flagellin from P. aeruginosa and E. coli to investigate flagellin-induced
inflammasome activation. Flagellin was fused to the cytosolic translocation domain of
anthrax lethal factor (LFn) to enable efficient cytosolic delivery. LFn binds to anthrax
protein protective antigen (PA), which delivers LFn-flagellin fusion protein into the
cytoplasm through receptor-mediated endocytosis.[59, 145] In this study, we explored the
role of the C-terminal D1 domain of flagellin in NAIP5/NLRC4 inflammasome activation.
We found that even though the flagellin C-terminal D0 domain is enough for NAIP/NLRC4
inflammasome activation for the full-length flagellin, the C-terminal D1 domain also
participates in the interaction with NAIPs. Our findings indicate the important role flagellin
C-terminal D1 domain in ligand recognition and inflammasome activation.
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3.2

Materials and methods
3.2.1

Construction of wild-type and mutant flagellin plasmid DNAs

FliC was fused to the cytosolic translocation domain of anthrax lethal factor (LFn)
to enable efficient cytosolic delivery. LFn binds to anthrax protein protective agent (PA),
which delivers the LFn-FliC fusion protein into the cytoplasm through receptor-mediated
endocytosis.[59, 145] P. aeruginosa flagellin gene and the constructed Pa-Ec-100aa, EcPa100aa, and Pa-Ec-11aa gene were digested with BamHI and XhoI and ligated into
similarly digested vector pET28a-LFn which was previously constructed in our lab. Sitedirected mutagenesis was conducted using the QuickChange mutagenesis kit following the
manufacturer’s instruction (Agilent Technologies) to construct point mutation flagellin.
PaD1EcD0 and EcD1PaD0 were synthesized and fused to E. coli flagellin and P.
aeruginosa flagellin, respectively. Myc-tag was then inserted to the N-terminal of each
plasmid for the transfection and co-immunoprecipitation experiment. The constructed
plasmids are shown in table 2.

3.2.2

LFn fusion protein expression and purification

As described previously,[119] proteins were expressed using LPS free E. coli strain
ClearColi BL21(DE3) (Lucigen Corporation, Cat#60810) at 37 °C for 4 hours with 500
μM IPTG after OD600 reached 0.6-0.8. Bacteria were collected and lysed in 50 mM TrisHCl and 300 mM NaCl. Proteins containing a His-tag were purified by affinity
chromatography using HisPur Ni-NTA resin (Thermo Scientific, Cat#88222). Proteins
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were then eluted with 250 mM imidazole in 50 mM Tris-HCL and 300 mM NaCl, and
subsequently dialyzed against PBS to remove imidazole. Protein concentrations were
determined by measuring their absorption at 280 nm before sterile filtration.

3.2.3

In vivo study

C57BL6 mice (10-12 weeks old) were injected with 3 μg of LFn-fliC or LFn- PaR488Q without PA, as indicated. Blood samples were collected before or at various time
(90 min, 4 h, and 8 h) following injection of the bacterial proteins. To determine the
inflammasome activation, blood samples were collected via retro-orbital bleeding. Blood
samples were centrifuged at 10,000 g for 1 minute at room temperature to obtain plasma.
IL-1β, IL-6, and TNFα were measured using ELISA following the manufacturer’s
instruction.

3.2.4

Bone marrow derived macrophage (BMDM) culture and stimulation

BMDMs were prepared as described previously,[120] and seeded into 12-well cell
culture plate (1 mL/well) or 96-well cell culture plate (100 µL/well) at a density of 1 x 106
cells/mL of RPMI-1640 medium containing 15% L929-cell conditioned medium (LCM).
BMDMs were allowed to settle overnight and refreshed with Opti-MEM (Life
Technologies, Cat#31985-070) before purified proteins were added. For the study of
cytotoxicity, supernatant samples and cell pellets were collected 90 min after stimulation.
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3.2.5

Lactate dehydrogenase cytotoxicity assay

To determine cell viability, the lactate dehydrogenase (LDH) CytoTox 96 NonRadioactive Cytotoxicity Assay kit (Promega, Cat#G1780) was used. 50 μl of CytoTox 96
Reagent was added to each well of 96-well plate followed by 50 μl of supernatant samples
and incubated for 10min at room temperature or until a sufficient colorimetric change was
visible. The reaction was stopped using the LDH stop solution, and the plate was read on
a Cytation 5 at 490 nm.

3.2.6

Western blotting

For detection of active caspase-1 and IL-1β cleavage by western blotting, cells were
washed with cold PBS and lysed with SDS sample buffer. Culture supernatants were
precipitated with 1/10 volume of 2% sodium cholate and 1/10 volume of 100%
trichloroacetic acid (TCA) and then dissolved in the SDS sample buffer. Total protein from
6

lysates and supernatants (equivalent to 1 ×10 cells) was analyzed by western blotting for
multiplex detection. Both pro-caspase-1 and p20 caspase-1 were determined using anticaspase-1(p20) (Adipogen, Cat#AG-20B-0042) at 1:1000 dilution. Pro-IL-1β and IL-1β
(p17) were detected using anti-IL-1β (GeneTex Cat#GTX74034) at 1:1000 dilution. Blots
were imaged using the BIO-RAD ChemiDoc MP imaging system.
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3.2.7

Co-immunoprecipitation binding assay

HEK 293T cells expressing recombinant flagellin and NAIP5 were solubilized in
modified RIPA Buffer (50 mM Tris, pH 7.4, 10 mM MgCl2, 150 mM NaCl, 1% NP-40, 1
mM sodium orthovanadate, 1 mM NaF), and complete protease inhibitor cocktail P8340
(Sigma). Cell lysates were incubated with 2 μg/ml of a polyclonal antibody against HA,
Myc, or mouse IgG, and further incubated with protein G agarose beads (Sigma). After 36 washes with lysis buffer, immunoprecipitates were analyzed by SDS polyacrylamide gel
electrophoresis and immunoblotting with antibodies against Myc or HA.
3.2.8

Statistical analysis

Statistical analysis was performed in Prism GraphPad 9.0.0. Statistical analysis was
performed using one-way ANOVA with Dunnett’s multiple comparisons for multiple
groups and two-way ANOVA repeated measures with Holm-Sidak multiple comparisons
for time point studies. A p value <0.05 was considered significant.
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Table 1. Primers used in this study
Construct
Ec SalI-F
Ec SalI-R
Pa_Ec-11aa-F
Pa_Ec-11aa-R
Pa-R488Q-R
Pa-A482Q-R
Pa-L479V-R
Primers for quickchange
Pa-L479V-F
Pa-L479V-R
Pa-A482Q-F
Pa-A482Q-R
Pa-R488Q-F
Pa-R488Q-R
Ec-Q497R-F
Ec-Q497R-R
Pa-R488K-F
Pa-R488K-R
Primers for fastcloning
Myc-Pa-F
Myc-Pa-R
Myc-Ec-F
Myc-Ec-R

Primer (5’-3’)
TTCTTCGTCGAC
ACCAGTGCAGGCACTGCAACCAAA
TTCTTCGTCGAC
GGTTTCAGTGGTCAGTTTACCT
TTCTTCGGATCC
ATGGCCCTTACAGTCAACACGAACATTGCTTCCCT
TTCTTCCTCGAGTTAACCCTGCAGCAGAGACA
GAACCTGCTGCGGTACGTTGGCCTGGGCCAGGAT

TTCTTCGGATCC
TTAACCCTGCAGCAGGCTCAGGA
TTCTTCGGATCC
TTAGCGCAGCAGGCTCAGGACCTGCTGCGG
TTCTTCGGATCCTTAGCG
CAGCAGGCTCAGGACCGCCTGCGGTACCTGGTT
AGGCCAACCAGGTACCGCAGGCGGT
ACCGCCTGCGGTACCTGGTTGGCCT
AGCTGCCGCAGCAGGTCCTGAGCCT
AGGCTCAGGACCTGCTGCGGCAGCT
TGAGCCTGCTGCAGGGTTAACTCGAG
CTCGAGTTAACCCTGCAGCAGGCTCA
AGGTTCTGTCTCTGCTGCGCGGTTAA
TTAACCGCGCAGCAGAGACAGAACCT
TCCTGAGCCTGCTGAAATAACTCGAG
CTCGAGTTATTTCAGCAGGCTCAGGA
AAACTCATCTCAGAAGAGGATCTG
GCCCTTACAGTCAACACG
TTCTGAGATGAGTTTTTGTTCCATGGATCCCCGTTGATC
AAACTCATCTCAGAAGAGGATCTG
GCACAAGTCATTAATACC
TTCTGAGATGAGTTTTTGTTCCATGGATCCCCGTTGATC
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Table 2. Plasmid constructed in this study
Name
Pa-Ec_100aa
Pa-Ec_11aa
Ec-Pa_100aa
Pa-R488Q
Pa-A482Q
Pa-L479V
Pa-R488K
Ec-Q497R
Pa-Ec_D1
Ec-Pa_D1
Ec-Pa_D1-Q497R
PaD1EcD0
EcD1PaD0
Myc-Pa-Ec_100aa
Myc-Pa-Ec_11aa
Myc-Ec-Pa_100aa
Myc-Pa-R488Q
Myc-Pa-A482Q
Myc-Pa-L479V
Myc-Pa-R488K
Myc-Ec-Q497R
Myc-Pa-Ec_D1
Myc-Ec-Pa_D1
Myc-Ec-Pa_D1-Q497R

Construction
P. aeruginosa flagellin C-terminal 100 amino acids are replaced
by E. coli flagellin C-terminal 100 amino acids
P. aeruginosa flagellin C-terminal 11 amino acids are replaced
by E. coli flagellin C-terminal 11 amino acids
E. coli flagellin C-terminal 100 amino acids are replaced by P.
aeruginosa flagellin C-terminal 100 amino acids
P. aeruginosa flagellin 488 arginine is mutated to glutamine
P. aeruginosa flagellin 482 alanine is mutated to glutamine
P. aeruginosa flagellin 479 leucine is mutated to valine
P. aeruginosa flagellin 488 arginine is mutated to lysine
E.coli flagellin 497 glutamine is mutated to arginine
P. aeruginosa flagellin C-terminal D1 domain is replaced by E.
coli flagellin C-terminal D1 domain
E. coli flagellin C-terminal D1 domain is replaced by P.
aeruginosa flagellin C-terminal D1 domain
Ec-Pa_D1 glutamine 497 is mutated to arginine
Synthesized fragment with P. aeruginosa flagellin C-terminal D1
domain and E. coli flagellin C-terminal D0 domain
Synthesized fragment with E. coli flagellin C-terminal D1
domain and P. aeruginosa flagellin C-terminal D0 domain
Myc tag is added at N-terminal of Pa-Ec_100aa
Myc tag is added at N-terminal of Pa-Ec_11aa
Myc tag is added at N-terminal of Ec-Pa_100aa
Myc tag is added at N-terminal of Pa-R488Q
Myc tag is added at N-terminal of Pa-A482Q
Myc tag is added at N-terminal of Pa-L479V
Myc tag is added at N-terminal of R488K
Myc tag is added at N-terminal of Ec-Q497R
Myc tag is added at N-terminal of Pa-Ec_D1
Myc tag is added at N-terminal of Ec-Pa_D1
Myc tag is added at N-terminal of Ec-Pa_D1-Q497R
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3.3

Results

3.3.1

C-terminal domains of P. aeruginosa flagellin plays a more important role in
NAIP/NLRC4 inflammasome activation

Flagellin is known to interact with NAIP through the D0 domain. To elucidate
whether N-terminal or C-terminal D0 domain plays role in flagellin induced NAIP/NLRC4
inflammasome activation, E. coli and P. aeruginosa flagellin C-terminal D1 and D0
domain were exchanged with each other (Ec-Pa_100aa and Pa-Ec_100aa). NAIP/NLRC4
inflammasome activation by Ec-Pa_100aa was evident by the release of LDH into the
supernatant, and caspase-1 activation and IL-1β cleavage. In contrast, Pa-Ec_100aa failed
to induce pyroptosis of BMDMs, caspase-1 activation, or IL-1β cleavage. These results
indicate that C-terminal D1 and D0 domain are more important than the N-terminal D1 and
D0 domain in full-length P. aeruginosa flagellin induced NAIP/NLRC4 inflammasome
activation. (Figure 3.1A, B) Further in vitro study of replacement of P. aeruginosa
flagellin C-terminal 11 amino acid residues with E. coli flagellin (Pa-Ec_11aa) shows that
the last 11 amino acid residues of P. aeruginosa flagellin are essential for flagellin induced
NAIP/NLRC4 inflammasome activation. (Figure 3.1A) These data indicate that flagellin
C-terminal domains play a more important role in NAIP/NLRC4 inflammasome activation
than N-terminal domains.
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Figure 3.1. P. aeruginosa flagellin C-terminal domains are critical in NAIP/NLRC4
inflammasome activation.
(A-B) BMDMs from C57BL/6J WT were incubated with 1 μg/ml of LFn fused
recombinant flagellin from P. aeruginosa with PA for 90 min. Cell viability was assessed
by measuring LDH release into the supernatant, and caspase-1 activation and IL-1β
cleavage were detected by western blot.

3.3.2

P. aeruginosa flagellin C-terminal arginine is critical for inflammasome
activation but not for NAIP recognition

To further explore the role of the C-terminus of flagellin in inflammasome
activation, further mutagenesis experiments were performed to replace the flagellin Cterminal last 11 amino acids. There are three different amino acid residues between P.
aeruginosa and E. coli flagellin among the last 11 residues. (Figure 3.2A) Site-direct point
mutation of the three residues (Pa-L479V, Pa-A482Q, Pa-R488Q) in vitro study results
indicate that the last arginine of P. aeruginosa flagellin is critical for the activation of
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NAIP/NLRC4 inflammasome, (Figure 3.2B) which is consistent with a previous
study.[146] While the in vivo study indicated that Pa-R488Q still induced the release of the
proinflammatory cytokine, in vitro study was then performed and the result illustrated that
Pa-R488Q can induce inflammasome activation and pyroptosis at a higher dose. (Figure
3.2C, D) These data indicate that the mutation of flagellin C-terminal arginine lowers the
toxicity of flagellin, but not affects the interaction between flagellin and NAIP.
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Figure 3.2. P. aeruginosa flagellin C-terminal arginine is essential for NAIP/NLRC4
inflammasome activation.
(A) The alignment of C-terminal last 11 amino acids from E. coli and P. aeruginosa
flagellin. (B-C) BMDMs from C57BL/6J WT were incubated with 1 μg/ml of LFn fused
recombinant flagellin from P. aeruginosa with PA for 90 min. Cell viability was assessed
by measuring LDH release into the supernatant, and caspase-1 activation and IL-1β
cleavage were detected by western blot. (D) C57BL/6J mice were injected intravenously
with 3 μg of LFn-fliC and LFn-Pa-R488Q from P. aeruginosa with PA (n=5 for all
experimental groups). One asterisk, p<0.05; two asterisks, P < 0.01; three asterisks,
P<0.001; one-way ANOVA with Dunnett’s multiple comparisons.
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3.3.3

C-terminal arginine mutation did not affect NLRC4 recruitment and
phosphorylation

It has been reported that the phosphorylation of NLRC4 ser 533 is critical for the
activation of NAIP/NLRC4 inflammasome.[147] To determine how the C-terminal
arginine plays its role in NAIP/NLRC4 inflammasome activation, it was mutated to lysine
and glutamine (Pa-R488K and PA-R488Q) to explore if the side chain length of amino acid
matters in the inflammasome activation. In vitro study shows that with the treatment of
mutant Pa-R488K, the cell viability was significantly increased, and the activation of
caspase-1 and cleavage of IL-1β was significantly decreased. (Figure 3.3A) Mutation of
arginine to glutamine eliminated the activation of caspase-1 and cleavage of IL-1β, the
LDH release result indicates that Pa-R488Q mutation cannot induce cell death at a lower
dose. (Figure 3.2B) However, the mutants still can interact with NAIP5 and induce
phosphorylation of NLRC4. (Figure 3.3B, C) These results indicate that both the positive
charge and length of the side chain are essential for the function of flagellin. To further
explore the critical role of arginine played in flagellin induced NAIP/NLRC4
inflammasome activation, E. coli flagellin glutamine 497 was mutated to arginine (EcQ497R). In vitro study indicates that Ec-Q497R is not able to induce cell pyroptotic death,
either the activation of caspase-1 and IL-1β cleavage. (Figure 3.3A) These results
illustrated that even though P. aeruginosa flagellin C-terminal arginine is critical for its
function, however, arginine alone is not enough to make E. coli flagellin virulent.
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Figure 3.3. C-terminal arginine is essential for the function of P. aeruginosa flagellin, the
mutation of it abrogates inflammasome activation but not affects NAIP binding or NLRC4
phosphorylation.
(A) BMDMs from C57BL/6J WT were incubated with 1 μg/ml of LFn fused recombinant
flagellin from P. aeruginosa with PA for 90 min. Cell viability was assessed by measuring
LDH release into the supernatant, and caspase-1 activation and IL-1β cleavage were
detected by western blot. (B) Co-immunoprecipitation assays of P. aeruginosa flagellin
and NAIP5. The mutation of arginine to glutamine doesn’t affect the interaction between
flagellin and NAIP5. (C) NLRC4 phosphorylation with P. aeruginosa flagellin treatment.
BMDMs from C57BL/6J WT were incubated with 1 μg/ml of LFn fused recombinant
flagellin from P. aeruginosa with PA for 90 min. NLRC4 phosphorylation from the
supernatant and cell lysate was detected by western blot.
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3.3.4

P. aeruginosa flagellin C-terminal D1 domain plays a role in flagellin-induced
inflammasome activation

It has been reported that the D0 domain alone can interact with NAIP and cause
inflammasome activation. Besides, the D0 domain also participates in flagellin TLR5
interaction, while whether the D1 domain plays a role in flagellin NAIP interaction remains
unknown. To explore whether the D1 domain of flagellin contributes to flagellin NAIP
interaction, P. aeruginosa flagellin C-terminal D1 domain replaced by E. coli flagellin Cterminal D1 domain (Pa-Ec_CD1) was constructed and tested. It is interesting that PaEc_CD1 neither induce cell pyroptotic death, nor inflammasome activation which depicted
as caspase-1 activation and IL-1β cleavage. (Figure 3.4 A) These data indicate that P.
aeruginosa flagellin C-terminal D1 domain plays a role in inflammasome activation and
subsequent pyroptosis.
To further prove whether C-terminal D1 domain of flagellin participates in flagellin
induced inflammasome activation. E. coli flagellin C-terminal D1 domain was then
replaced by P. aeruginosa flagellin C-terminal D1 domain (Ec-Pa_CD1). As our expected,
Ec-Pa_CD1 cannot induce NAIP/NLRC4 inflammasome activation. While the mutation of
C-terminal glutamine to arginine (Ec-Pa_CD1-Q497R) make the flagellin virulent and can
induce inflammasome activation and subsequent pyroptotic cell death in a dose dependent
manner. (Figure 3.4 A, B)
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Figure 3.4. Flagellin C-terminal D1 domain contributes to NAIP/NLRC4 inflammasome
activation.
(A) BMDMs from C57BL/6J WT were incubated with 1 μg/ml of LFn fused recombinant
flagellin Pa-Ec_CD1, Ec-Pa_CD1, and Ec-Pa_CD1 Q497R with PA for 90 min,
respectively. Cell viability was assessed by measuring LDH release into the supernatant,
and caspase-1 activation and IL-1β cleavage were detected by western blot. (B) BMDMs
from C57BL/6J WT were incubated with 1 μg/ml, 5 μg/ml, and 10 μg/ml of LFn fused
recombinant flagellin Ec-Pa_CD1 Q497R with PA for 90 min, respectively. Cell viability
was assessed by measuring LDH release into the supernatant, and caspase-1 activation and
IL-1β cleavage were detected by western blot.
3.4

Discussion
The bacterial flagellar system is one of the most complex and dynamic biological

proteinaceous structures which provide mobility of flagellated bacteria. Flagellin monomer
is also known as a virulence factor that can be recognized by extracellular receptor TLR5
and intracellular receptor NAIP of host cells. However, the mechanisms for how flagellin
interact with NAIP remains elusive.
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Previous studies indicated that the flagellin C-terminal D1 domain is essential for
TLR5 recognition, and the C-terminal D0 domain participates in TLR5 recognition as well.
Besides, the D0 domain is critical for NAIP5/6 recognition and interaction. Several studies
have illustrated the amino acid residues on the flagellin C-terminal that are essential for
NAIP recognition. In this study, we identified the role of the flagellin C-terminal D1
domain in flagellin NAIP recognition and interaction. P. aeruginosa flagellin can interact
with NAIP5, while the exchange of the C-terminal D1 domain with the corresponding
sequence from E. coli flagellin, which cannot be recognized by NAIP5, lost its interaction
with NAIP5 and subsequent inflammasome activation. It is interesting that when E. coli
flagellin C-terminal D1 domain exchanged with corresponding sequence from P.
aeruginosa flagellin together with the glutamine 497 mutated to arginine made E. coli
flagellin virulent and can induce inflammasome activation and subsequent pyroptosis in a
dose dependent manner. We propose this would be related to the conformational change
due to the difference of C-terminal D1 domain between virulent and non-virulent flagellin.
The slightly change of C-terminal D0 domain direction pointed out that flagellin Cterminal D1 domain plays its role in NAIP recognition through affecting the folding
direction of C-terminal D0 domain. Flagellin C-terminal D0 domain cannot bind to NAIP
binding pocket because of the slightly change in its folding direction.
Structural study of flagellin unveiled the mechanisms of flagellin-NAIP interaction.
It has been reported that the flagellin D0 domain is essential for flagellin-TLR5 interaction,
however, whether the D1 domain plays a role in flagellin-NAIP interaction remains
elusive. Even though we proved that the flagellin C-terminal D1 domain participates in
interaction between flagellin and NAIP, how does the C-terminal D1 domain contribute to
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the interaction with NAIP and NLRC4 inflammasome activation remain elusive. It has
been reported that the NAIP/NLRC4 inflammasome can be activated by the D0 domain
alone.[86] More studies are needed to prove whether the C-terminal D1 domain exchange
caused conformation change of flagellin and thus indirectly affected the interaction
between the D0 domain and NAIP5, or it indeed participates in the interaction of flagellin
with NAIP. Besides, it is proved the single C-terminal arginine mutation abrogates the
flagellin induced NAIP/NLRC4 inflammasome activation since the mutant still can interact
with NAIP5 and induce NLRC4 phosphorylation. How does it work and why the arginine
is critical remain elusive. However, whether the length or the positive charge of the
arginine side chain contributes more to flagellin-NAIP interaction, or both are essential for
the interaction remains to be proved. In our study, the C-terminal arginine mutation did not
affect the interaction between flagellin and NAIP and the mutant can still lead to
phosphorylation of NLRC4 but is not capable of activating inflammasome at a lower
dosage. In vivo study showed that mutants without the C-terminal arginine still induced
proinflammatory cytokine release. The result further indicated that interaction between
flagellin and NAIP and downstream NLRC4 phosphorylation is essential but not enough
for inflammasome activation. We are proposing if any other mediators participate in the
NLRC4 inflammasome activation, either between NAIP and NLRC4 or between NLRC4
and downstream factors such as ASC and caspase 1.
In conclusion, our structural and biochemical data showed that (i) the last arginine
from tested flagellin is essential for NAIP/NLRC4 inflammasome activation. Both the
positive charge and length of mutated residue are critical for the function of flagellin. (ii)
The C-terminal D1 domain plays a role in the function of full-length flagellin through
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affecting the folding direction of C-terminal D0 domain. (iii) In contrast to the C-terminal
three leucine residues mutation will make flagellin lose its interaction with NAIP,[59] the
mutation of arginine to other residues did not affect its binding to NAIP. Flagellin has been
widely used in vaccines investigation and some of them are in preclinical trials; it also has
been applied in cancer therapy. To get a thorough understanding of the structure function
relationship would be helpful for its using in vaccine development and any other therapy
methods.
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CHAPTER 4. DISCUSSION AND FUTURE WORK

The bacteria flagellar system is one of the most complex and dynamic biological
proteinaceous structures which provide motility of flagellated bacterial. While our
knowledge of the filament and its component flagellin monomer has increased in the past
few decades, many open questions remain. There is still a long way to go to fully
understand the process of filament growth and its pathogenesis.
Despite unprecedented insights into the structure and activation mechanisms of the
NAIP-NLRC4 inflammasome, there are still gaps in our knowledge. In infectious diseases,
NAIP-NLRC4 exploits the structural and functional conservation of virulence factors
encoded by many pathogenic bacteria, such as S Typhimurium and P aeruginosa. Structural
study of flagellin unveiled the mechanisms of flagellin-NAIP interaction.[85] It has been
reported that the flagellin D0 domain is essential for flagellin-TLR5 interaction, however,
whether the D1 domain plays a role in flagellin-NAIP interaction remains elusive.[56]
Even though we proved that the flagellin C-terminal D1 domain participates in interaction
between flagellin and NAIP, how the D1 domain contributes to the interaction with NAIP
and NLRC4 inflammasome activation needs further exploration. More studies are needed
to explore whether the D1 domain caused conformation change of flagellin, or if it indeed
participated in the interaction between flagellin and NAIP. Besides, it is reported the single
C-terminal arginine mutation abrogates the flagellin induced NAIP/NLRC4 inflammasome
activation,[146] since the mutant still can interact with NAIP5 and induce NLRC4
phosphorylation, how it works and why the arginine is critical remain elusive. However,
whether the length or the positive charge of the arginine side chain contributes more to
64

flagellin-NAIP interaction, or both are essential for the interaction remains to be proved.
In our study, C-terminal arginine mutation did not affect the interaction between flagellin
and NAIP, it can also cause the phosphorylation of NLRC4, but not for inflammasome
activation in a lower dosage. In vivo study showed that the mutation of C-terminal arginine
can still induce proinflammatory cytokine release. The result further indicated that
interaction between flagellin and NAIP and downstream NLRC4 phosphorylation is
essential but not enough for inflammasome activation. We are proposing if any other
mediators participate in the NLRC4 inflammasome activation, either between NAIP and
NLRC4 or between NLRC4 and downstream factors such as ASC and caspase 1.
Generally,

flagellin

induced

immune

response

causes

the

release

of

proinflammatory cytokines. The studies also illustrated that flagellin induces transcription
of proinflammatory cytokines through interaction with TLR5.[55, 72, 137] However, our
study showed that flagellin induced cytokine release in vivo is inflammasome activation
and subsequent pyroptosis dependent, but not TLR5 dependent. Interestingly, extracellular
flagellin cannot induce cytokine release either in vivo or in vitro. While cytosol flagellin
induces cytokine release only with the presence of inflammasome activation and
subsequent pyroptosis. How inflammasome activation induces the transcription of
proinflammatory cytokines remains elusive. The potential connection between
inflammasome activation and TLRs induced transcription pathway still need to be
explored. Whether inflammasome activation directly or indirectly induce proinflammatory
cytokine release is still a mystery. It is interesting that in our study, flagellin cannot induce
primary macrophage release cytokine except IL-1β even with the presence of
inflammasome activation and pyroptosis, which contradicts with previous research. While
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the depletion of macrophages and monocytes in vivo eliminated the release of
proinflammatory cytokines induced by flagellin which indicates that macrophages and
monocytes are the major sources for proinflammatory cytokines expression and release in
vivo. Whether the in vivo environment is essential for the expression and transcription of
proinflammatory cytokines remains unknown.
At least 4 mouse NAIPs are required to recognize multiple bacterial ligands
whereas a single human NAIP and its isoforms succeed to do so. It remains unclear how
hNAIP binds multiple ligands and if additional upstream sensors are required for hNAIP
or if it binds directly to those bacterial ligands. Answers to these questions would shed light
on the field of innate immune recognition and inflammasome activation. Further, the role
of the remaining murine NAIPs 3, 4, and 7 in NLRC4 inflammasome activation remains
unexplored. Given that the C57BL/6 mice only express NAIPs 1, 2, 5, and 6, the function
of the remaining murine NAIPs will likely require interrogation using mouse strains of
other genetic backgrounds.
NAIP-NLRC4 inflammasome limits bacterial proliferation and dissemination
through the activation of multiple pathways, including secretion of signaling molecules
such as IL-1β and IL-18, pyroptosis, and clearance of infected cells from the host. Mice
with NLRC4 deficiency do not readily succumb to infection in a specific-pathogen-free
environment, indicating that lacking NLRC4 in mice does not lead to hyper-susceptibility
to environmental microbiota.[148] Besides, some mammalian species, such as pigs, lack
functional NLRC4, and NAIPs.[149] NAIP-NLRC4 inflammasome activation might
protect against certain pathogens invasion in mice. However, over activation of NAIPNLRC4 would cause autoinflammatory conditions, such as systemic inflammation, sepsis,
66

and death in humans and mice. Therefore, the evolutionary advantage of encoding NAIPNLRC4, against a backdrop of the inherent risk of triggering overt inflammation, probably
extends beyond protection against bacterial infection.
In autoinflammatory conditions associated with gain-of-function mutations of
NLRC4, progress has been made to transfer fundamental discoveries to clinical practice.
Patients with macrophage activation syndrome have been successfully treated by targeting
cytokines production caused by constitutive NAIP-NLRC4 inflammasome activation.[148]
Another issue that requires attention is the consequences of sustained inhibition of
inflammasome-associated cytokines in patients since these proinflammatory cytokines are
critical for the host to control infection. Would these complications be alleviated if NAIP
or NLRC4 is specifically inhibited instead? Unfortunately, no pharmacological inhibitors
have been discovered. Identifying safe and efficacious compounds that specifically inhibit
NAIP or NLRC4 could provide more targeted therapy for these patients. Future studies
will yield insights into the role of NAIP-NLRC4 in clinical manifestations beyond
infectious diseases and identify pharmacologic compounds and host targets to accelerate
the development of therapies to improve patient care.
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